Dividends Calendar Earnings Calendar
NTLA

NTLA | Intellia Therapeutics Inc

Intellia Therapeutics Inc
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 4.1B
  • Prev closed: 13.36
  • Open: 13.87
  • High: 13.91
  • Low: 13.37
  • 52 week low: 9.18
  • 52 week high: 19
  • Dividends:No Dividends

Next ER: August 4, 2022  Before Market Opens



Top Stories (NTLA)

    About the Company

    Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 3, 2022
    August 4, 2022-1.33 / -1.2814.03M / 9.42MBeat!
    May 5, 2022-1.96 / -1.1111.25M / 8.54MBeat!
    February 24, 2022-1.09 / -0.94912.85M / 8.26MBeat!
    November 4, 2021-0.97 / -0.84717.2M / 8.66M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 4, 2022 65.43 61.90
    65.89
    57.63
    2.91M -8.74%
    Aug 3, 2022 71.70 73.00
    76.45
    70.31
    2.84M 11.93%
    Aug 2, 2022 64.06 62.18
    65.09
    61.89
    661.30K 2.10%
    Aug 1, 2022 62.74 63.84
    65.79
    61.94
    676.74K -3.12%
    Jul 29, 2022 64.76 64.99
    65.13
    63.02
    759.29K -1.37%
    Jul 28, 2022 65.66 67.69
    69.34
    64.60
    613.18K -2.77%
    Jul 27, 2022 67.53 65.75
    67.66
    64.36
    1.20M 3.34%
    Jul 26, 2022 65.35 65.36
    67.23
    63.89
    824.13K -0.18%
    Jul 25, 2022 65.47 64.67
    65.54
    61.35
    596.06K 0.49%
    Jul 22, 2022 65.15 68.46
    68.66
    64.22
    1.16M -4.47%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:104

    News

    News for (NTLA)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Nessan Bermingham, PhD
    • General Counsel :  José Rivera

    Talk about Intellia Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 4, 2022 (Same day)

    baba syna tm gpro newr clls trip w z swks k expe 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 73
    HOLD 27
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Peers / Similar stocks 

    xlv 

    Other stocks 

    ibm tgt aap sig pdco azo tvpt low afsi amg cgc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis